Product Pipeline
Our product pipeline is comprised of the following anti-tumor compounds:
Adva-27a
Difluoro-Etoposide™
Entering Phase I later this year (Lead Compound)
Adva-R46
RNAi Anti-Cancer drug candidate
Soon to enter animal studies phase
Adva-33c
Difluoro-Carboplatin™
Currently in preclinical phase